163 related articles for article (PubMed ID: 32671989)
1. Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation.
Haciislamoglu E; Gungor G; Aydin G; Canyilmaz E; Guler OC; Zengin AY; Yenice KM
J Appl Clin Med Phys; 2020 Sep; 21(9):82-89. PubMed ID: 32671989
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
3. Second Cancer Risk after simultaneous integrated boost radiation therapy of right sided breast cancer with and without flattening filter.
Dobler B; Maier J; Knott B; Maerz M; Loeschel R; Koelbl O
Strahlenther Onkol; 2016 Oct; 192(10):687-95. PubMed ID: 27534409
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of volumetric-arc therapy versus sliding window intensity-modulated radiotherapy in postoperative treatment for primary soft tissue sarcoma of the thigh.
Ortiz González I; Morera Cano D; Roncero Sánchez R; Mateos Salvador P; Valencia Blanco L; Vidal Borrás M; Aymar Salís N; Gadea Quinteiro J; Jiménez Jiménez E; Gelabert JF; Pardo Masferrer J
Asia Pac J Clin Oncol; 2019 Dec; 15(6):371-376. PubMed ID: 31321885
[TBL] [Abstract][Full Text] [Related]
5. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
6. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
[TBL] [Abstract][Full Text] [Related]
8. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
9. Secondary malignancy risk for patients with localized prostate cancer after intensity-modulated radiotherapy with and without flattening filter.
Treutwein M; Loeschel R; Hipp M; Koelbl O; Dobler B
J Appl Clin Med Phys; 2020 Dec; 21(12):197-205. PubMed ID: 33147377
[TBL] [Abstract][Full Text] [Related]
10. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
[TBL] [Abstract][Full Text] [Related]
11. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
[TBL] [Abstract][Full Text] [Related]
12. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
15. Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma.
Mazonakis M; Kachris S; Damilakis J
Med Phys; 2020 Jul; 47(7):2805-2813. PubMed ID: 32266979
[TBL] [Abstract][Full Text] [Related]
16. Standardized flattening filter free volumetric modulated arc therapy plans based on anteroposterior width for total body irradiation.
Frederick R; Hudson A; Balogh A; Cao JQ; Pierce G
J Appl Clin Med Phys; 2020 Mar; 21(3):75-86. PubMed ID: 32043760
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
[TBL] [Abstract][Full Text] [Related]
18. Prone Positioning on a Belly Board Decreases Rectal and Bowel Doses in Pelvic Intensity-Modulated Radiation Therapy (IMRT) for Prostate Cancer.
Kószó R; Varga L; Fodor E; Kahán Z; Cserháti A; Hideghéty K; Együd Z; Szabó C; Borzási E; Szabó D; Müllner K; Varga Z; Maráz A
Pathol Oncol Res; 2019 Jul; 25(3):995-1002. PubMed ID: 29882196
[TBL] [Abstract][Full Text] [Related]
19. Lifetime radiation-induced sarcoma risk in patients subjected to IMRT or VMAT for uterine cervix carcinoma.
Mazonakis M; Lyraraki E; Damilakis J
Phys Eng Sci Med; 2021 Jun; 44(2):573-579. PubMed ID: 33909230
[TBL] [Abstract][Full Text] [Related]
20. Volumetric-modulated arc therapy and intensity-modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators.
Treutwein M; Hipp M; Koelbl O; Dobler B
J Appl Clin Med Phys; 2017 Sep; 18(5):307-314. PubMed ID: 28857432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
